Targeted modulation of the neuroinflammatory response after spinal cord injury: The ongoing quest for the "holy grail"

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 2685-2687

  Stahel, Philip F ^a   Flierl, Michael A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1379; UNCLASSIFIED DRUG;

COMPLEMENT ACTIVATION; NERVE DEGENERATION; NEUROMODULATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; SPINAL CORD INJURY;

EID: 78650206848     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100408     Document Type: Note

References (22)

1. Chan CC: Inflammation: beneficial or detrimental after spinal cord injury? Recent Pat CNS Drug Discov 2008, 3:189-199
2. Buchli AD, Rouiller E, Mueller R, Dietz V, Schwab ME: Repair of the injured spinal cord: a joint approach of basic and clinical research. Neurodegen Dis 2007, 4:51-56
3. Hurlbert RJ: Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000, 93:1-7 (Pubitemid 30457375)
4. Sauerland S, Maegele M: A CRASH landing in severe head injury. Lancet 2004, 364:1291-1292
5. Kortbeek JB, Al Turki SA, Ali J, Antoine JA, Bouillon B, Brasel K, Brenneman F, Brink PR, Brohi K, Burris D, Burton RA, Chapleau W, Cioffi W, Collet e Silva Fde S, Cooper A, Cortes JA, Eskesen V, Fildes J, Gautam S, Gruen RL, Gross R, Hansen KS, Henny W, Hollands MJ, Hunt RC, Jover Navalon JM, Kaufmann CR, Knudson P, Koestner A, Kosir R, Larsen CF, Livaudais W, Luchette F, Mao P, McVicker JH, Meredith JW, Mock C, Mori ND, Morrow C, Parks SN, Pereira PM, Pogetti RS, Ravn J, Rhee P, Salomone JP, Schipper IB, Schoettker P, Schreiber MA, Smith RS, Svendsen LB, Taha W, van Wijngaarden- Stephens M, Varga E, Voiglio EJ, Williams D, Winchell RJ, Winter R. Advanced trauma life support, edition 8: the evidence for change. J Trauma 2008, 64:1638-1650
6. Hurlbert RJ, Hamilton MG: Methylprednisolone for acute spinal cord injury: 5-year practice reversal. Can J Neurol Sci 2008, 35:41-45
7. Stahel PF, Barnum SR: The role of the complement system in CNS inflammatory diseases. Expert Rev Clin Immunol 2006, 2:445-456
8. Rebhuhn J, Botvin J: Complement elevation in spinal cord injury. Ann Allergy 1980, 44:287-288
9. Qiao F, Atkinson C, Song H, Pannu R, Singh I, Tomlinson S: Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma. Am J Pathol 2006, 169:1039-1047
10. Qiao F, Atkinson C, Shunmugavel A, Morgan BP, Song H, Tomlinson S: The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury. Am J Pathol 2010, 177:3061-3070
11. Leinhase I, Holers VM, Thurman JM, Harhausen D, Schmidt OI, Pietzcker M, Taha ME, Rittirsch D, Huber-Lang M, Smith WR, Ward PA, Stahel PF: Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci 2006, 7:55 (Pubitemid 46277111)
12. Thurman JM, Kraus DM, Girardi G, Hourcade D, Kang HJ, Royer PA, Mitchell LM, Giclas PC, Salmon J, Gilkeson G, Holers VM: A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol Immunol 2005, 42:87-97
13. Leinhase I, Rozanski M, Harhausen D, Thurman JM, Schmidt OI, Hossini AM, Taha ME, Rittirsch D, Ward PA, Holers VM, Ertel W, Stahel PF: Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. J Neuroinflammation 2007, 4:13
14. Stahel PF, Morganti-Kossmann MC, Kossmann T: The role of the complement system in traumatic brain injury. Brain Res Rev 1998, 27:243-256
15. Morgan BP: Regulation of the complement membrane attack pathway. Crit Rev Immunol 1999, 19:173-198
16. Anderson AJ, Robert S, Huang W, Young W, Cotman CW: Activation of complement pathways after contusion-induced spinal cord injury. J Neurotrauma 2004, 21:1831-1846
17. Reynolds DN, Smith SA, Zhang YP, Mengsheng Q, Lahiri DK, Morassutti DJ, Shields CB, Kotwal GJ: Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury. Ann NY Acad Sci 2004, 1035:165-178
18. Galvan MD, Luchetti S, Burgos AM, Nguyen HX, Hooshmand MJ, Hamers FP, Anderson AJ: Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury. J Neurosci 2008, 28:13876-13888
19. Holers VM, Thurman JM: The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 2004, 41:147-152
20. Thurman JM, Holers VM: The central role of the alternative complement pathway in human disease. J Immunol 2006, 176:1305-1310
21. Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM: Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J Immunol 2006, 177:1904-1912
22. Banda NK, Levitt B, Glogowska MJ, Thurman JM, Takahashi K, Stahl GL, Tomlinson S, Arend WP, Holers VM: Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice. J Immunol 2009, 183:5928-5937